1U S FDA, FDA approves ixabepilone for injection(lxempra) for two indications [ EB/OL ]. [ 2007 - 08 - 18 ], http:// www, fda. gov/cder/Offices/OODP/whatsnew/ixabepilone. htm.
2LI W S, THORNTON J E, GUO Z R, et al. A process for the preparation of epothilone analogs and intermediates: WO, 2002/060904 [ P]. 2002 - 08 - 08.
3KIM S H, BORZILLERI R M. A process for the preparation of rlng-opened epothilone intermediates which are useful for the preparation of epothilone analogs: WO, 1999/27890 [ P]. 1999 - 06 - 10.
4BORZILLERI R M, ZHENG X, SCHMIDT R J, et al. A novel application of a Pd(0)-catalyzed nucleophilic substitution reaction to the regioand stereoselective synthesis of lactam analogues of the epothilone natural products[J] .J Am Chem Soc, 2000, 122 (37) :8890- 8897.
4Hofle G H, Bedorf H, Steinmetz H, et al. Epothilone A and B-Novel 16-Membered Macrolides with Cytotoxic Activity: Isolation, Crystal Structure, and Conformation in Solution [J]. AngewChem Int Ed Engl, 1996,35:1567.
5Girth K, Bedorf N, HOfle G, etal. Epothilone A and B: Antifungal and Cytotoxic Compounds from Sorangium cellulosum (Myxobacteria) Production, Physico-chemical and Biological Properities[J]. J Antibiol, 1996,49: 560.
6Hofle G, Glaser N, Leibold T, etal. Semisynthesis and deg radation of the tubulin inhibitors epothilone and tubulysin [J]. Pure Appl Chem, 2003,75.. 167.
7Su DS, Ballog A, Meng D. Total synthesis of epothilone B: An extension of the Suzuki coupling method and insights into structure-activity relationships of the Epothilones[J]. Angezv Chem Int Ed, 1997,36:757.
8Meng D, Kamenecka T, Danishefsky S, et al. Second generation epothilones: discovery of fludelone and its extraordinary antitumor properties[J]. Ange'w Chem Int Ed , 1996,35: 2801.
9Schinzer D, Limberg A, Bauer A, et al. Total Synthesis of (-)-Epothilone A[J]. Angevo Chem Int Ed , 1997,:36: 523.
10Nicolaou KC, He Y, Vourloumis D, et al. The olefin Metathesis Approach to Epothilone A and Its Analogues[J]. JAm Chem Soc, 1997,119:7960.
